Home › Funds › Two Sigma Investments › MBX
Two Sigma Investments position in MBX
MBX BIOSCIENCES INC · Health Care
Latest position (Q2 2026)113.47K sh
Reported value held$6.26M
Portfolio Weight0.00%
First reportedQ1 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 33.83K | $249.69K | New |
| Q1 2025 | 33.83K | $249.69K | New |
| Q3 2025 | 13.59K | $237.77K | New |
| Q4 2025 | 138.57K | $4.37M | Add |
| Q1 2026 | 115.08K | $3.43M | Reduce |
| Q2 2026 | 113.47K | $6.26M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MBX
- Fidelity Management & Research (FMR) 5.32M sh · $293.82M · Q2 2026
- Wellington Management Group 4.98M sh · $274.76M · Q2 2026
- BlackRock Inc 3.32M sh · $183.47M · Q2 2026
- Vanguard Group 1.82M sh · $57.33M · Q4 2025
- Geode Capital Management 773.07K sh · $42.68M · Q2 2026
- Goldman Sachs Group 459.00K sh · $25.34M · Q2 2026
- Marshall Wace 401.88K sh · $22.18M · Q2 2026
- Bank of America Corp 298.93K sh · $16.50M · Q2 2026
- UBS Group AG 272.75K sh · $15.06M · Q2 2026
- Franklin Resources 252.66K sh · $13.95M · Q2 2026
- Morgan Stanley 248.56K sh · $13.72M · Q2 2026
- Northern Trust Corp 246.68K sh · $13.62M · Q2 2026